1. SEIKAGAKU CORPORATION
  2. Sustainability
  3. Our Policy
Our Policy
サブ-ナビゲーション
  • TOP
  • News Release
  • Who we are
  • ”Hyaluronic Acid” Expedition
  • What is Glycoscience
  • Management Policy
  • Highlights
  • Stock Information
  • Our R&D
  • Sustainability
    • Sustainability Management
    • Materiality
    • Stakeholder Engagement
    • Environmental Policy
    • Environmental Impact Reduction Initiatives
    • Initiatives for Biodiversity
    • Information Disclosure Based on the TCFD Recommendations
    • Social Contribution Activities
    • Human Resource Development
    • Diversity and Work-Life Balance
    • Corporate Governance
    • Compliance
    • Risk Management
    • ->Our Policy
    • ESG Data Book
    • External Evaluations
  • Investors
  • Our Company
  • Privacy Policy
  • Terms of Use
  • Sitemap

Our Policy

List of Our Policies

Environment

  • Environmental Policy※
  • Biodiversity Policy※

Society

  • Human Rights Policy※
  • Procurement Policy※
  • Business Partner Code of Conduct for Sustainable Procurement※
  • Occupational Safety and Health Policy※

Corporate Governance

  • Corporate Philosophy※
  • Basic Sustainability Policy※
  • R&D Basic Policy
  • Disclosure Policy
  • Information Security Policy
  • Privacy Policy
  • Corruption and Bribery Prevention Policy※
  • SKK Group Compliance Code of Conduct (summary)※

※This policy is also applied to major overseas subsidiaries.

This document contains the our policies shown above.

  • List of Our Policies (November 2026) （4,386KB）

This link will direct you to a third-party site.（Another window opens.）

Please click here

Step back to the Seikagaku Corporation website

The Seikagaku Corporation website uses cookies to personalize contents and offer a better browsing experience. Please click the Accept botton. （Read more）

Accept

生化学工業株式会社
  • 日本語
  • ”Hyaluronic Acid” Expedition
  • Contact Us　

Who we are

What is Glycoscience

What is Glycoscience

Are glucides sweet?

Glycoscience in one minute

Introduction to the Glycoscience

Glycoscience in one minute

Glycoscience in one minute

”Hyaluronic Acid” Expedition

”Hyaluronic Acid” Expedition

Our R&D

Our R&D

R&D Basic Policy

R&D Structure

R&D Pipeline

Process of new drug development

Intellectual Property

R&D Basic Policy

R&D Basic Policy

R&D Pipeline

R&D Pipeline

Sustainability

Sustainability

Sustainability Management

Materiality

Stakeholder Engagement

Environmental Policy

Environmental Impact Reduction Initiatives

Initiatives for Biodiversity

Information Disclosure Based on
the TCFD Recommendations

Social Contribution Activities

Human Resource Development

Diversity and Work-Life Balance

Corporate Governance

Compliance

Risk Management

Our Policy

ESG Data Book

External Evaluations

Materiality

Materiality

Investors

Investors

News Release

What's New

Management Policy

Highlights

IR Library

IR Schedule

Shareholder Information

IR E-mail Alert

Message from President & CEO

Message from President & CEO

Our Company

Our Company

Greeting

Corporate Philosophy

History

Corporate Profile

Member of the Board

Organizational Chart

Corporate Governance

Compliance

Risk Management

Information Security

Value Creation Process

Social Contribution Activities

Business Activities

Corporate Philosophy

Corporate Philosophy

Business Activities

Business Activities
生化学工業株式会社

Who we are

What is Glycoscience

Are glucides sweet?

Glycoscience in one minute

Introduction to the Glycoscience

  • Part 1　Invitation to Glycoscience
  • Part 2　Fertilization
  • Part 3　Source of Energy
  • Part 4　Extracellular matrix 1
  • Part 5　Extracellular matrix 2
  • Part 6　Cell proliferation and differentiation
  • Part 7　Blood type
  • Part 8　Cancer
  • Part 9　Viral infection
  • Part 10　Applications and Developments

”Hyaluronic Acid” Expedition

Hyaluronic Acid - I am also in your home

Hyaluronic Acid- Everywhere in your body

Hyaluronic Acid- This is what I am!

Hyaluronic Acid- How I work in your body

Story Time

Our R&D

R&D Basic Policy

R&D Structure

R&D Pipeline

Process of new drug development

Intellectual Property

Sustainability

Sustainability Management

Materiality

Stakeholder Engagement

Environmental Policy

Environmental Impact Reduction Initiatives

Initiatives for Biodiversity

Information Disclosure Based on
the TCFD Recommendations

Social Contribution Activities

Human Resource Development

Diversity and Work-Life Balance

Corporate Governance

Compliance

Risk Management

Our Policy

ESG Data Book

External Evaluations

Investors

News Release

What's New

Management Policy

  • Message from President & CEO
  • Mid-term Management Plan
  • R&D Pipeline
  • Profit Distribution Policies
  • Business Risks

Highlights

  • Business Performance
  • Business Performance（Quarter）
  • Cash Flow
  • Business Performance Data Download

IR Library

  • Summary of Financial Results
  • Presentation Material
  • Corporate Report

IR Schedule

Shareholder Information

  • Stock Information
  • Shareholder Composition
  • Profit Distribution
  • General Meeting of Shareholders
  • Analyst Coverage
  • Stock Price

IR E-mail Alert

Our Company

Greeting

Corporate Philosophy

History

Corporate Profile

Member of the Board

Organizational Chart

Corporate Governance

Compliance

Risk Management

Information Security

Value Creation Process

Social Contribution Activities

Business Activities

  • Business Segment
  • Products
    • Pharmaceuticals and Medical Devices
    • Bulk Products
      • Sodium Hyaluronate
      • Sodium Chondroitin Sulfate
    • LAL Business
    • Contract development and manufacturing organization (CDMO)
  • Production
  • Quality Compliance
  • Contact Us
  • 日本語
To page top
To page top

Who we are

What is Glycoscience

Are glucides sweet?

Glycoscience in one minute

Introduction to the Glycoscience

”Hyaluronic Acid” Expedition

Hyaluronic Acid - I am also in your home

Hyaluronic Acid- Everywhere in your body

Hyaluronic Acid- This is what I am!

Hyaluronic Acid- How I work in your body

Story Time

Our R&D

R&D Basic Policy

R&D Structure

R&D Pipeline

Process of new drug development

Intellectual Property

Sustainability

Sustainability Management

Materiality

Stakeholder Engagement

Environmental Policy

Environmental Impact Reduction Initiatives

Initiatives for Biodiversity

Information Disclosure Based on
the TCFD Recommendations

Social Contribution Activities

Human Resource Development

Diversity and Work-Life Balance

Corporate Governance

Compliance

Risk Management

Our Policy

ESG Data Book

External Evaluations

Investors

News Release

What's New

Management Policy

Highlights

IR Library

IR Schedule

Shareholder Information

IR E-mail Alert

Our Company

Greeting

Corporate Philosophy

History

Corporate Profile

Member of the Board

Organizational Chart

Corporate Governance

Compliance

Risk Management

Information Security

Value Creation Process

Social Contribution Activities

Business Activities

Copyright © SEIKAGAKU CORPORATION All rights Reserved.

  • Privacy Policy
  • Terms of Use